I have an important question (fo me, anyway) In last

New Post Public Reply Private Reply Replies (0) Message Board
Sent108
444
I have an important question (fo me, anyway)

In last nights call it was stated that they now have proof that Leronlimab crosses the blood brain barrier, at least in certain cases. Does anyone know how they can see this? I assume Dr Patterson’s receptor occupancy test is used, but how do they see it? Does it light up under an MRI scan?

I ask because I’d like to have a talk with my wife’s oncologist, who despite being an attending physician at St Barnabas Medical Center (part of the CD 12 trial) never hear of Leronlimab. When I mentioned it to her previously, she didn’t think any mabs crossed the blood brain barrier.

I’d like to go into this conversation armed with as much information as I can.

I also want to thank so many on this forum for sharing their knowledge, wisdom, sense of humor, and investment acumen. I am a first time bio investor and have no knowledge of bio/chem science at all. Don’t even think I took chemistry in high school. I’ve learned a lot from listening and reading voraciously since I invested in Cytodyn, and this board has been a great resource. I also have to throw in, “There’s no place like Ohm!

Thanks everyone!


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

JBM Institutional Multifamily Advisors Lists Casa Bella Apartments

Updated Category News Views 298

Casa Bella Apartments Exclusively Listed by JBM Advisors JBM Institutional Multifamily Advisors has proudly taken the exclusive listing for Casa Bella on Westshore, a luxurious apartment community designed with a unique charm and modern elegance. Originally conceived as a high-end condominium, these apartments boast exquisite finishes and innovative floor plans that...

Continue Reading
When AI Misbehaves, Protocol Over Firewalls

Updated Category News Views 5

Rethinking AI Security: It's About Agency, Not Merely Access AI's gone rogue and it ain't just about beefing up your firewall anymore. Recent events have exposed a glaring oversight: we're slapping band-aids on gaping wounds, assuming network security is the whole game. Enter Causum, a feisty little company, daring to tip the scales. Introducing the AI Agency Protocol...

Continue Reading
Clarity Pediatrics Brings Innovative ADHD Care to Texas Families

Updated Category News Views 295

Clarity Pediatrics Introduces Comprehensive ADHD Care in Texas Clarity Pediatrics, a leader in pediatric specialty care, is enhancing its reach by offering comprehensive ADHD care to families with children aged 5-17 in Texas. This innovative model is transforming the pediatric care journey, making it easier for families to access much-needed services. Adapting to Growing...

Continue Reading
Overnight Borrowing Costs Surge Amid Chinese Lunar New Year

Updated Category News Views 130

Overnight Borrowing Costs Surge in China Recently, financial institutions in China have experienced a significant spike in overnight borrowing costs, reaching as high as 16%. This surge can be attributed to tightening cash supplies in the market, particularly as the upcoming week-long Lunar New Year approaches. Cash Market Tightness Ahead of the Holiday The spike in...

Continue Reading
Transforming $1000 into a $23,000 Investment Journey

Updated Category News Views 70

A Look Back: The Rise of Lululemon Athletica Lululemon Athletica (NASDAQ: LULU) has carved out an impressive niche in the athletic apparel market, showcasing remarkable growth over the past 15 years. An investor who put $1,000 into LULU stock at that time would now see a staggering value of approximately $22,882.57. This incredible return exemplifies the power of...

Continue Reading